TG Therapeutics | TGTX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 25.5B 547M 2026-06
Ardelyx USD 109.57M 20.96M 2026-03
Arrowhead Research USD 283.35M 11.87M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Curis USD 14.97M 898K 2026-03
Gilead Sciences USD 11.02B 1.54B 2026-06
J&J USD 54.9B 2.82B 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Novartis USD 31.75B 374M 2026-06
Novavax USD 330.57M 11.89M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Verastem USD 66.84M 5.42M 2026-03
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06